Adaptin Bio (APTN) Other Accumulated Expenses (2022 - 2025)

Adaptin Bio has disclosed Other Accumulated Expenses across 4 years of filings, most recently posting $25000.0 for Q4 2025.

• In Q4 2025, Other Accumulated Expenses changed N/A year-over-year to $25000.0; the TTM figure through Dec 2025 stood at $25000.0 (changed N/A YoY), while the FY2025 annual figure was $25000.0, changed N/A from the prior year.
• Other Accumulated Expenses came in at $25000.0 for Q4 2025 at Adaptin Bio, up from $12576.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $44750.0 in Q3 2024 to a low of $12576.0 in Q1 2025.
• Average Other Accumulated Expenses over 4 years is $29439.4, with a median of $32000.0 recorded in 2023.
• Year-over-year, Other Accumulated Expenses surged 113.33% in 2023 and tumbled 65.31% in 2025.
• Over 4 years, Other Accumulated Expenses stood at $15000.0 in 2022, then surged by 113.33% to $32000.0 in 2023, then surged by 39.84% to $44750.0 in 2024, then slumped by 44.13% to $25000.0 in 2025.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $25000.0 in Q4 2025, $12576.0 in Q1 2025, and $44750.0 in Q3 2024.